Greenlees C - Search Results

1

Hypertension evaluation and management in new young patients: are we doing our female patients a disservice?

Greenlees C, Hosseinzadeh S, Delles C, McGinnigle E. Greenlees C, et al. Blood Press. 2024 Dec;33(1):2387909. doi: 10.1080/08037051.2024.2387909. Epub 2024 Aug 5. Blood Press. 2024. PMID: 39102372 Free article.

2

Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patients with advanced solid tumours.

Johnson ML, Wang JS, Falchook G, Greenlees C, Jones S, Strickland D, Fabbri G, Kennedy C, Elizabeth Pease J, Sainsbury L, MacDonald A, Schalkwijk S, Szekeres P, Cosaert J, Burris H 3rd. Johnson ML, et al. Among authors: greenlees c. Br J Cancer. 2023 May;128(10):1906-1915. doi: 10.1038/s41416-023-02185-2. Epub 2023 Mar 4. Br J Cancer. 2023. PMID: 36871042 Free PMC article. Clinical Trial.

3

Determinants of employment of recently arrived Mexican immigrant wives.

Greenlees CS, Saenz R. Greenlees CS, et al. Int Migr Rev. 1999 Summer;33(2):354-77. Int Migr Rev. 1999. PMID: 12319735

4

A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin.

Gordon FH, Hamilton MI, Donoghue S, Greenlees C, Palmer T, Rowley-Jones D, Dhillon AP, Amlot PL, Pounder RE. Gordon FH, et al. Among authors: greenlees c. Aliment Pharmacol Ther. 2002 Apr;16(4):699-705. doi: 10.1046/j.1365-2036.2002.01205.x. Aliment Pharmacol Ther. 2002. PMID: 11929387 Free article. Clinical Trial.

5

A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease.

Gordon FH, Lai CW, Hamilton MI, Allison MC, Srivastava ED, Fouweather MG, Donoghue S, Greenlees C, Subhani J, Amlot PL, Pounder RE. Gordon FH, et al. Among authors: greenlees c. Gastroenterology. 2001 Aug;121(2):268-74. doi: 10.1053/gast.2001.26260. Gastroenterology. 2001. PMID: 11487536 Clinical Trial.

6

Drugs in development for the treatment of multiple sclerosis: antigen non-specific therapies--an update.

Donoghue S, Greenlees C. Donoghue S, et al. Among authors: greenlees c. Expert Opin Investig Drugs. 2000 Jan;9(1):167-71. doi: 10.1517/13543784.9.1.167. Expert Opin Investig Drugs. 2000. PMID: 11060669 Review.

7

The effects of L-arginine on neointimal formation and vascular function following balloon injury in heritable hyperlipidaemic rabbits.

Greenlees C, Wadsworth RM, Martorana PA, Wainwright CL. Greenlees C, et al. Cardiovasc Res. 1997 Aug;35(2):351-9. doi: 10.1016/s0008-6363(97)00122-3. Cardiovasc Res. 1997. PMID: 9349398

8

Vasorelaxant and antiaggregatory properties of the endothelium: a comparative study in normocholesterolaemic and hereditary and dietary hypercholesterolaemic rabbits.

Greenlees C, Wainwright CL, Wadsworth RM. Greenlees C, et al. Br J Pharmacol. 1996 Dec;119(7):1470-6. doi: 10.1111/j.1476-5381.1996.tb16060.x. Br J Pharmacol. 1996. PMID: 8968557 Free PMC article.

9

Nitric oxide synthase inhibitors 7- and 6-nitroindazole relax smooth muscle in vitro.

Medhurst AD, Greenlees C, Parsons AA, Smith SJ. Medhurst AD, et al. Among authors: greenlees c. Eur J Pharmacol. 1994 Apr 11;256(1):R5-6. doi: 10.1016/0014-2999(94)90626-2. Eur J Pharmacol. 1994. PMID: 7517888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters